Studies have pointed out a correlation between ZAP70 expression in CLL cells and IGVH status, and showed that ZAP70 positive patients have an aggressive course, an immediate treatment requirement, longer therapy time, and lower survival rates [8,9,10]. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.